Page last updated: 2024-09-03

op 2507 and dinoprostone

op 2507 has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(op 2507)
Trials
(op 2507)
Recent Studies (post-2010)
(op 2507)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
330129,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomyop 2507 (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, T; Kai, T; Kamada, N; Kim, YI; Kitano, S; Sugimachi, K; Tatsuma, T1

Other Studies

1 other study(ies) available for op 2507 and dinoprostone

ArticleYear
Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver.
    Transplantation, 1994, Oct-27, Volume: 58, Issue:8

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspartate Aminotransferases; Cryoprotective Agents; Dinoprostone; Endotoxins; Epoprostenol; Female; Ischemia; Liver; Prostaglandins; Swine; Thromboxane B2

1994